Pierre Michel

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

Medicine, Oncology, Pharmacology +13

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

Laurent Bedenne, Pierre Michel, Olivier Bouché et al. · Journal of Clinical Oncology · 2007 · 1.3K citations · Full text

Medicine, Oncology, Surgery +11

Risk factors for anastomotic leakage after resection of rectal cancer

Éric Rullier, J L Garrelon, Pierre Michel et al. · British journal of surgery · 1998 · 904 citations

Medicine, Oncology, Surgery +15

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

Frédéric FIORE, Frédéric Blanchard, F. Charbonnier et al. · British Journal of Cancer · 2007 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of FcγRIIa-FcγRIIIa Polymorphisms and <i>KRAS</i> Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

Frédéric Bibeau, Evelyne Lopez‐Crapez, Frédéric FIORE et al. · Journal of Clinical Oncology · 2009 · 512 citations

Medicine, Oncology, Pharmacology +16